chartexchange

IPSC
Century Therapeutics, Inc. Common Stock
stockNASDAQ

Market OpenNov 17, 2026 10:38:11 AM EST
1.53USD-6.402%(-0.11)87,760
Pre-marketNov 17, 2026 8:43:30 AM EST
1.6399USD-0.006%(-0.0001)
1.5300Bid1.5400Ask0.0100Spread
Loading…
Loading…
278.75M
Healthcare
Biotechnology
HQ
Philadelphia, PA, USA
Previous Close
$1.63
Beta
2.06
52-Week High
$3.04 2026-03-10
52-Week Low
$0.44 2025-11-17
SMA 50
$1.63
SMA 200
$2.06
Avg. Vol 10D
838,140
Avg. Vol 30D
999,154
Avg. Vol 90D
729,008
Relative Vol
0.09
181.60M
101.77M
32,026,662
1.1300%
66,416
IPSC Profile

Century Therapeutics, Inc. specializes in adult stem cells to develop curative cell therapy products for cancer that overcome the limitations of first generation cell therapies as well as provides testing and research services.

IPSC Performance
PeriodPriceDateChangeBeta
1W1.682026-11-10-8.63%1.334
1M1.372026-10-16+12.04%2.662
3M1.952026-08-17-21.28%2.141
6M2.282026-05-18-32.67%1.637
1Y0.482025-11-17+219.59%2.063
2Y1.252024-11-18+22.80%—
5Y20.952021-11-17-92.67%1.349
IPSC Stock Summary

Century Therapeutics, Inc. Common Stock (NASDAQ:IPSC) stock price today is $1.54, and today's volume is 86,839. IPSC is down 6.402% today. The 30 day average volume is 999,154. IPSC market cap is $278.75M with 181.60M shares outstanding.